In the global fight against "Covid-19”, AstraZeneca has become a household name for millions of people around the world. It has supplied over 2.7 billion doses of the vaccine globally, with approximately two-thirds going to low- and middle-income countries, according to Mene Pangalos Executive Vice-President, BioPharmaceuticals R&D.
In a wide-ranging interview, Pangalos told Asharq Al-Awsat the vaccine has helped prevent 50 million Covid-19 cases, five million hospitalizations, and saved more than one million lives.
